About
NexPlasmaGen incorporated is a Canadian privately held company dedicated to providing noninvasive plasma technologies to the health care systems to fight cancer. We first focus on reducing breast cancer recurrence rates to improve patients' survival rates at difference local stages of the disease and to reduce hospital's and patient's costs associated with recurrence. Our plasma technology is safe, efficient, versatile and portable and has been proven in preclinical trials. Safety clinical trials are in preparation for 2023.
Technologies
Microsoft Office 365Mobile FriendlyGoogle Tag ManagerGoogle MapsWordPress.orgYouTubeApacheGoogle Font APIGoogle Maps (Non Paid Users)RenderIoTAIRemote
Keywords
oncology & breast cancermedical equipment manufacturingoncologytargeted cancer therapypreclinical cancer researchresidual cancer cell eliminationcontrolled plasma environmentclinical trial preparationplasma-based cancer ablationcold plasma therapycancer treatmentbreast cancerhealthcare technologysurgical adjunct technologypost-surgical cancer treatmentpatented plasma technologyplasma jet deviceb2bplasma device patentspreclinical trialshealthcarereactive species deliverynon-thermal plasmamedical device innovationin vitro and in vivo studiesservicesbiotechnologyrecurrence reductionmedical equipment and supplies manufacturingcancer recurrence prevention
Company Information
- Employees9
- Founded2008
Location
3801 Avenue Wilson, Montreal, Quebec, Canada, H4A 2T7
